Loading asset research
IGC Pharma Inc. Common Stock
IGCNYSE · USD · StocksQuote as of · Exchange session not verified$0.28
0.00%
Today
IGC
Loading 1D prices…
Market cap
$28.8M
Volume
413.6K
52w high
$0.4552w low
$0.24Company profile
IGC Pharma Inc. Common Stock
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
Potomac, MD, United States
Employees
70
Fiscal year end
1231
CIK
1326205
Session & valuation
Open$0.29
Previous close$0.28
Day high$0.29
Day low$0.28
30-day avg. volume883.5K
Outstanding shares103.4M
Diluted EPS-$0.05
Latest annual period
P/E (trailing)-5.60
P/E (forward)-3.48
Price / book4.64
Beta0.49
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RADXRadiopharm Theranostics Limited American Depositary Shares | $28.6M | — | — | -$5.28 | -3.88% | Buy |
| BRNSBarinthus Biotherapeutics plc American Depositary Shares | $30.2M | $0.00 | — | -$1.64 | 0.00% | Buy |
| BYSIBeyondSpring Inc. Ordinary Shares | $31.4M | $0.00 | — | -$0.02 | -0.39% | Unrated |
| BCTXBriaCell Therapeutics Corp. Common Shares | $31.6M | $0.00 | — | -$5.73 | +0.83% | Unrated |
| ABVCABVC BioPharma Inc. Common Stock | $26.1M | $0.00 | — | -$0.39 | +0.41% | Unrated |